Zura Bio (ZURA) Other Non Operating Income (2022 - 2026)
Zura Bio's (ZURA) quarterly Other Non Operating Income came in at -$43000.0 in Q1 2026, down 760.0% year-on-year from $6515.2 in Q1 2025, and down 7.5% quarter-over-quarter from -$40000.0 in Q4 2025.
Zura Bio (ZURA) Other Non Operating Income (2022 - 2026) Analysis & Trends
Zura Bio's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$43000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 760.0% year-over-year to -$43000.0 in Q1 2026; TTM through Mar 2026 was $222000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $260000.0, up 828.57% from the prior year.
- Other Non Operating Income eased to -$43000.0 in Q1 2026 per ZURA's latest filing, from -$40000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $987000.0 in Q3 2023 and bottomed at -$1.4 million in Q4 2023.
- The 5-year median for Other Non Operating Income is -$1500.0 (2022), against an average of $14312.5.
- Biggest YoY gain for Other Non Operating Income was 20150.0% in 2023; the steepest drop was 15377.78% in 2023.
- Year by year, Other Non Operating Income stood at $9000.0 in 2022, then slumped by 15377.78% to -$1.4 million in 2023, then soared by 98.62% to -$19000.0 in 2024, then tumbled by 110.53% to -$40000.0 in 2025, then fell by 7.5% to -$43000.0 in 2026.
- Per Business Quant, the three latest ZURA Other Non Operating Income figures stand at -$43000.0 (Q1 2026), -$40000.0 (Q4 2025), and -$47000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | 987,000.00 |
| Jun 30, 2023 | 405,000.00 |
| Mar 31, 2023 | -10,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | -34,000.00 |
| Jun 30, 2022 | 2,000.00 |